Shire shares get lift from 20pc earnings increase

Shire’s earnings jumped 20pc in the third quarter, beating expectations and taking its shares 2.17pc higher. Revenue rose 7pc year on year in the quarter, hitting $3.7bn (£2.8bn), after strong sales of immunology treatments offset a weaker performance from other areas. The FTSE 100 group reiterated its guidance for the full year.